The Therapeutic Goods Administration (TGA) has issued comprehensive guidance on how to handle recalls and other market actions for therapeutic goods in Australia. This guidance ensures companies and consumers are aware of procedures for maintaining safety and compliance when issues arise.
Key highlights include:
- Types of Market Actions:
- Recall: Requires returning or disposing of affected products (e.g., incorrect tablets in vitamin bottles).
- Product Alert: Informs users about potential concerns (e.g., reduced battery performance in medical devices).
- Product Correction: Fixes the identified issue (e.g., updating a mobile app or reinforcing a wheelchair).
- Quarantine: Advises users to avoid using the product until further notice (e.g., bacterial contamination in saline products).
- Staying Updated:
- Sponsors must inform consumers of any issues through letters, emails, phone calls, websites, or social media.
- The Database of Recalls, Product Alerts, and Product Corrections (DRAC) allows searching for published market actions.
- Translated Resources: Information on market actions is available in five languages for broader accessibility.
- Public Action: Most actions do not require direct intervention, though some may require users to stop using products or consult healthcare professionals.
This guidance reinforces TGA’s commitment to public safety, transparency, and timely communication in managing therapeutic goods.
Source
Select Mandate HA
Select Mandate Function